Senior Scientist – Translational Pharmacology & Biomarkers

Sarepta Therapeutics | Ex: BioAgilytix Labs

About

Ph.D. pharmacology and drug discovery scientist with deep expertise in vitro assay development, in vivo pharmacology, oxidative stress biology, translational pharmacology, biomarker strategy, and genetic medicines. Proven experience advancing RNA therapeutics through target validation and mechanism-of-action studies.

Work history

Senior Scientist – Translational Pharmacology & Biomarkers

Sarepta Therapeutics

11/2021 – 12/2025

Led scientific strategy for RNA and gene-therapy programs, integrating NGS, molecular, protein, and clinical data to evaluate MOA, target engagement, efficacy, and safety. Directed NGS studies, established biomarker frameworks, and developed advanced disease models.

B

Scientist II – Bioanalytical & Translational Research

BioAgilytix Labs

09/2020 – 11/2021

Directed assay development, qualification, and execution of RT-qPCR-based molecular assays and high-throughput workflows to support biomarker analysis and therapeutic assessment. Provided scientific leadership for assay optimization and troubleshooting.

Senior Investigator – Preclinical Disease Biology & RNA Therapeutics

Olix Pharmaceuticals

09/2019 – 08/2020

Led development and execution of disease-relevant in vitro and in vivo model pharmacology to evaluate GalNAc-siRNA therapeutic candidates. Designed cell-based screening strategies and conducted proof-of-concept studies.

B

Postdoctoral Fellow, T32 NIH Training Grant

Boston University School of Medicine

04/2017 – 09/2019

Conducted translational research investigating liver, cardiovascular, and neurological disease biology using gene modulation approaches. Utilized shRNA-mediated gene silencing and produced AAV vectors for gene modulation studies.

Expertise

Industry
1
Life Sciences & Biotech
Department
4
Biotech & Pharma R&DClinical & Medical AffairsHealth Economics & Market AccessRegulatory Affairs